Table 1 Demographic, clinical and laboratory characteristics of the TAK and GCA patients.
TAK, n = 25 | GCA, n = 20 | |
|---|---|---|
Age at diagnosis (yrs) | 24 (18–38) | 72 (67–78) |
Females, n (%) | 24 (96) | 12 (60) |
HLA-B52, n (%) | 10 (63), n = 16 | — |
BMI (kg/m2) | 18.8 (17.9–22.5) | 21.9 (19.2–23.6) |
Smoking | 5 (20) | 4 (20) |
Fever | 14 (56) | 14 (70) |
Ophthalmic symptoms | 0 (0) | 2 (10) |
Carotid bruit | 16 (64) | — |
Discrepancy of BP | 16 (64) | — |
Pulselessness | 6 (24) | — |
Cervical pain | 7 (28) | — |
Chest pain | 6 (24) | — |
Arthralgia | 7 (28) | — |
Aortic valve regurgitation | 6 (24) | — |
New headache | 8 (32) | 18 (90) |
Temporal artery abnormality | — | 18 (90) |
Jaw claudication | — | 7 (35) |
Scalp tenderness | — | 8 (40) |
Cerebral infarction | — | 1 (5) |
Coexisting PMR | — | 12 (60) |
Abnormal artery biopsy | — | 3 (50), n = 6 |
CRP (mg/dL) | 5.3 (1.2–11.1) | 6.7 (3.6–16.7) |
ESR (mm/h) | 79 (56–109) | 74 (55–93) |
Angiographic classification, n (%) | I: 1; IIa: 4; IIb: 7; III: 1; IV: 1; V: 11 | — |
Aortic lesions in computed tomography | — | 5 (33), n = 15 |
